Prostate cancer remains one of the most common cancers among men, affecting approximately 1 in 8. Early detection and accurate staging are crucial for optimal outcomes. While the PSA blood test has long been a cornerstone of screening, a more advanced imaging technique known as PSMA PET is emerging as a vital tool in the management of the disease.
Dr. Phillip Koo, Executive Vice President and Chief Medical Officer at the Prostate Cancer Foundation, explains that PSMA (prostate-specific membrane antigen) is a biomarker found on the surface of prostate cancer cells. Using a PET scan, doctors can visualize whether cancer has spread beyond the prostate, providing critical information for treatment planning. Remarkably, over 80 to 90% of prostate cancer patients express this biomarker, making PSMA imaging a highly relevant option for many.
Bill, a prostate cancer survivor and patient advocate, shares his journey with PSMA testing. Diagnosed 18 years ago, he took an active role in his care by researching and discovering PSMA. He brought this information to his doctor, and together they decided to incorporate the test into his treatment plan. Bill describes the experience as empowering because it gave him a clear picture of his disease status and helped guide subsequent decisions.
After receiving his PSMA scan results, Bill and his oncologist crafted a personalized plan of action. He emphasizes the importance of being an active participant in one's healthcare, stating, “Information is power.” He encourages patients to ask questions and persist in getting the answers they need.
Dr. Koo stresses the collaborative nature of deciding whether PSMA testing is appropriate. He advises patients to educate themselves about the procedure, enabling them to have informed conversations with their healthcare providers. “Knowing your PSMA status is vitally important to your cancer care,” he says.
For those seeking more information, Dr. Koo recommends visiting GetYourScan.com, a resource that provides comprehensive details about the PSMA scan and how to advocate for it.
The implications of PSMA testing are significant. By offering a clearer picture of the cancer's extent, it allows for more personalized and timely interventions, potentially improving outcomes. As prostate cancer remains a major health concern, empowering patients with knowledge about advanced diagnostic tools like PSMA PET is a critical step forward.
This article is sponsored by Novartis, highlighting the importance of patient-physician dialogue and the role of innovative imaging in prostate cancer management.
